Infection of T Lymphocytes in Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Children of Non-Asian Origin

被引:60
|
作者
Beutel, Karin [1 ]
Gross-Wieltsch, Ute [2 ]
Wiesel, Thomas [3 ]
Stadt, Udo Zur [1 ,4 ]
Janka, Gritta [1 ]
Wagner, Hans-Joachim [5 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, D-20246 Hamburg, Germany
[2] Olgahosp Stuttgart, Stuttgart, Germany
[3] Univ Witten Herdecke, Pediat Oncol Hematol Vest Kinder & Jugendklin Dat, Witten, Germany
[4] Childrens Canc Ctr Hamburg, Res Inst, Hamburg, Germany
[5] Univ Giessen, Dept Pediat Hematol & Oncol, Ctr Children & Adolescent Med, Giessen, Germany
关键词
Epstein-Barr virus; hemophagocytic lymphohistiocytosis; real-time polymerase chain reaction; T cells; ACTIVE EBV INFECTION; LYMPHOPROLIFERATIVE DISORDER; TREATMENT STRATEGIES; ADULT PATIENTS; CELL LYMPHOMA; VIRAL LOAD; GENE; QUANTIFICATION; PATHOGENESIS; EXPRESSION;
D O I
10.1002/pbc.22037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Epstein-Barr virus (EBV) is one of the most frequent triggers of hemophagocytic lymphohistiocytosis EBV-associated HLH (EBV-HLH) and ectopic infection of T cells has been particularly described in patients from Far East Asia. Procedure. In a cohort of 12 children with EBV-HLH treated in Germany, the EB viral load was detected by real-time polymerase chain reaction in plasma and peripheral blood mononuclear cells (PBMC). Virological and clinical data were analyzed retrospectively. Results. Among the 12 mainly German patients, children with underlying immunodeficiencies as well as otherwise healthy individuals were affected. The clinical Course ranged from a steroid-responding to a fatal disease despite intensive treatment. Increased EBV copy numbers in plasma and/or PBMC were found in all patients. Serial measurements reflected the course of the disease. Cell-type specific viral load was determined in seven patients and revealed EBV-infection of T cells in all of them. in contrast to the reported Asian patients a significant viral load was also found in B cells. Conclusions. T cell infection appears to be a typical feature of EBV-associated HLH irrespective of patients ethnic background and the clinical Course. Evaluation of cell-type specific infection should be considered when targeted therapy is applied. Pediatr Blood Cancer 2009;53:184-190. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 50 条
  • [31] Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: response to HLH-04 treatment protocol
    Jimenez-Hernandez, Elva
    Martinez-Villegas, Octavio
    Sanchez-Jara, Berenice
    Angelica Martinez-Martell, Maria
    Hernandez-Sanchez, Beatriz
    del Rocio Loza-Santiaguillo, Paloma
    Pedro-Matias, Eduardo
    Arellano-Galindo, Jose
    BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2016, 73 (01): : 26 - 30
  • [32] Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in a Patient With Behcet's Disease Treated With Adalimumab
    Kaneko, Shuya
    Tomomasa, Dan
    Hatano, Maho
    Irabu, Hitoshi
    Hayashi, Yuko
    Kanegane, Hirokazu
    Shimizu, Masaki
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (02)
  • [33] Emapalumab as a therapeutic intervention for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A case series
    Wang, Wen
    Yuan, Xiao
    Yu, Li
    Pei, Fuyu
    MEDICINE, 2024, 103 (39) : e39880
  • [34] Dermatopathic Lymphadenitis With Generalized Erythroderma in a Patient With Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
    Lee, Woo Jin
    Lee, Deok Woo
    Kim, Chae Hwa
    Won, Chong Hyun
    Chang, Sung Eun
    Lee, Mi Woo
    Choi, Jee Ho
    Moon, Kee Chan
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2010, 32 (04) : 357 - 361
  • [35] Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Mimicking Lymphoma on FDG PET/CT
    Pan, Qingqing
    Luo, Yaping
    Wu, Huanwen
    Ma, Yanru
    Li, Fang
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (02) : 125 - 127
  • [36] Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults
    Liu, Pengpeng
    Pan, Xiangyu
    Chen, Chong
    Niu, Ting
    Shuai, Xiao
    Wang, Jian
    Chen, Xuelan
    Liu, Jiazhuo
    Guo, Yong
    Xie, Liping
    Wu, Yu
    Liu, Yu
    Liu, Ting
    BLOOD, 2020, 135 (11) : 826 - 833
  • [37] A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice
    Sato, Kei
    Misawa, Naoko
    Nie, Chuanyi
    Satou, Yorifumi
    Iwakiri, Dai
    Matsuoka, Masao
    Takahashi, Rei
    Kuzushima, Kiyotaka
    Ito, Mamoru
    Takada, Kenzo
    Koyanagi, Yoshio
    BLOOD, 2011, 117 (21) : 5663 - 5673
  • [38] Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China
    Jin Ying-kang
    Xie Zheng-de
    Yang Shuang
    Lu Gen
    Shen Kun-ling
    CHINESE MEDICAL JOURNAL, 2010, 123 (11) : 1426 - 1430
  • [39] Comparison of plasma proteomic profiles of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and infectious mononucleosis
    Haruta, Kazunori
    Suzuki, Takako
    Yamaguchi, Makoto
    Fukuda, Yuto
    Torii, Yuka
    Takahashi, Yoshiyuki
    Ito, Yoshinori
    Kawada, Jun-ichi
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [40] Haploidentical hematopoietic stem cell transplantation for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
    Li, Zhihui
    Wang, Yini
    Wang, Jingshi
    Zhang, Jia
    Wang, Zhao
    LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 77 - 84